Trial Details
RECRUITINGBasic Information
| Clinical ID | c1621 |
|---|---|
| Identifier | NCT06693908 |
| Trial Title | A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Moderate to Severe Ulcerative Colitis |
| Interventions | DRUG: Vixarelimab |
Participant Information
| Sponsor | Genentech, Inc. |
|---|---|
| City | Berlin |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2025-03-31 |
|---|---|
| Primary Completion Date | 2026-04-03 |
| Completion Date | 2026-05-06 |